Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: A protocol
2019-01-01 Riva, S.; Bryce, J.; De Lorenzo, F.; Del Campo, L.; Di Maio, M.; Efficace, F.; Frontini, L.; Giannarelli, D.; Gitto, L.; Iannelli, E.; Jommi, C.; Montesarchio, V.; Traclo, F.; Vaccaro, C. M.; Gallo, C.; Perrone, F.
The future of Funds for Innovative Medicines: results from a Delphi Study
2021-01-01 Jommi, Claudio; Armeni, Patrizio; Bertolani, Arianna; Costa, Francesco; Otto, Monica
Prezzo, rimborso e accesso ai farmaci in Italia: le proposte di riforma di quattro panel di esperti
2019-01-01 Jommi, Claudio; Apolone, Giovanni; Cicchetti, Americo; Conte, Pierfranco; Fattore, Giovanni; Mantoan, Domenico; Marata, Annamaria; Schincariol, Paolo; Scroccaro, Giovanna; Tosolini, Francesca; Buzzetti, Giuliano
Early access programs and managed entry agreements for medicines in Italy: Results of a Focus Group (Early Access Programs and Managed Entry Agreement)
2021-01-01 Jommi, C.; Armeni, P.; Costa, F.; Alberti, C.; Bandello, F.; Bordonaro, R.; Caprodossi, A.; Di Maio, M.; Gaudioso, A.; Giuliani, G.; Langella, R.; Marata, A. M.; Patarnello, F.; Pinto, C.; Rasi, G.; Villa, F.
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency
2019-01-01 Villa, F.; Tutone, M.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G.; Jommi, C.
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates
2018-01-01 Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Borget, I.; Hutchings, A.; Flostrand, S.; Parnaby, A.; Jommi, C.
Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study
2018-01-01 Cozzolino, M.; Bolasco, P.; Ronco, C.; Conte, G.; Mene, P.; Mereu, M. C.; Di Luca, M.; Roccatello, D.; Rosati, A.; Jommi, C.; Costanzo, A. M.; Gualberti, G.; Di Luzio Paparatti, U.; Remuzzi, G.
Unmet clinical need and new therapeutic options
2022-01-01 Caprari, F.; Alfano, A.; Buzzetti, G.; Consoli, A.; De Braud, F.; Patarnello, F.; Pitrelli, A.; Riccaboni, M.; Rossi, G.; Samele, R.; Scaduto, D.; Viale, P.; Jommi, C.; Popoli, P.
CAR T-Cell Therapies in Italy: Patient Access Barriers and Recommendations for Health System Solutions
2022-01-01 Jommi, C.; Bramanti, S.; Pani, M.; Ghirardini, A.; Santoro, A.
Costs and outcome of care in subjects with a severe mental disorder
2003-01-01 Percudani, M.; Gerzeli, S.; Massagrandi, R.; Jommi, C.; Fattore, G.; Cerati, G.; Contini, A.
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study
2018-01-01 Jommi, C.; Armeni, P.; Battista, M.; di Procolo, P.; Conte, G.; Ronco, C.; Cozzolino, M.; Costanzo, A. M.; di Luzio Paparatti, U.; Concas, G.; Remuzzi, G.
Towards a more competitive Italy in clinical research: The survey of attitudes towards trial sites in Europe (the SAT-EU study™)
2015-01-01 Gehring, M.; Jommi, C.; Tarricone, R.; Cirenei, M.; Ambrosio, G.
Key drivers of innovativeness appraisal for medicines: The Italian experience after the adoption of the new ranking system
2021-01-01 Galeone, C.; Bruzzi, P.; Jommi, C.
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
2021-01-01 Ronco, V.; Dilecce, M.; Lanati, E.; Canonico, P. L.; Jommi, C.
Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service
2020-01-01 Armeni, P.; Borsoi, L.; Fornaro, G.; Jommi, C.; Grossi, F.; Costa, F.
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
2023-01-01 Drummond, Michael; Ciani, Oriana; Fornaro, Giulia; Jommi, Claudio; Dietrich, Eva Susanne; Espin, Jaime; Mossman, Jean; de Pouvourville, Gerard
Operational strategies to deal with the COVID-19 emergency: recommendations from the Italian national society SIAGASCOT following the introduction of vaccines against the SARS-CoV-2 infection
2023-01-01 Compagnoni, Riccardo; Cucchi, Davide; Klumpp, Raymond; Ronga, Mario; Berruto, Massimo; Di Giacomo, Giovanni; Randelli, Pietro S
Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise - a review
2023-01-01 Lubrano, Ennio; Scriffignano, Silvia; de Vlam, Kurt; Ronga, Mario; Perrotta, Fabio Massimo; Lories, Rik
Real-world use of Safinamide in motor fluctuating Parkinson's disease patients in Italy
2023-01-01 Bovenzi, Roberta; Liguori, Claudio; Canesi, Margherita; D'Amelio, Marco; De Pandis, Maria Francesca; Marini, Carmine; Monge, Alessandra; Padovani, Alessandro; Tessitore, Alessandro; Stefani, Alessandro; Zappia, Mario; SYNAPSES Study, Investigators Italian Group including; Comi, Cristoforo
Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy
2023-01-01 Cavaletti, Guido; Pizzamiglio, Chiara; Man, Albert; Engber, Thomas M; Comi, Cristoforo; Wilbraham, Darren
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: A protocol | 1-gen-2019 | Riva, S.; Bryce, J.; De Lorenzo, F.; Del Campo, L.; Di Maio, M.; Efficace, F.; Frontini, L.; Giannarelli, D.; Gitto, L.; Iannelli, E.; Jommi, C.; Montesarchio, V.; Traclo, F.; Vaccaro, C. M.; Gallo, C.; Perrone, F. | |
| The future of Funds for Innovative Medicines: results from a Delphi Study | 1-gen-2021 | Jommi, Claudio; Armeni, Patrizio; Bertolani, Arianna; Costa, Francesco; Otto, Monica | |
| Prezzo, rimborso e accesso ai farmaci in Italia: le proposte di riforma di quattro panel di esperti | 1-gen-2019 | Jommi, Claudio; Apolone, Giovanni; Cicchetti, Americo; Conte, Pierfranco; Fattore, Giovanni; Mantoan, Domenico; Marata, Annamaria; Schincariol, Paolo; Scroccaro, Giovanna; Tosolini, Francesca; Buzzetti, Giuliano | |
| Early access programs and managed entry agreements for medicines in Italy: Results of a Focus Group (Early Access Programs and Managed Entry Agreement) | 1-gen-2021 | Jommi, C.; Armeni, P.; Costa, F.; Alberti, C.; Bandello, F.; Bordonaro, R.; Caprodossi, A.; Di Maio, M.; Gaudioso, A.; Giuliani, G.; Langella, R.; Marata, A. M.; Patarnello, F.; Pinto, C.; Rasi, G.; Villa, F. | |
| Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency | 1-gen-2019 | Villa, F.; Tutone, M.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G.; Jommi, C. | |
| Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates | 1-gen-2018 | Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Borget, I.; Hutchings, A.; Flostrand, S.; Parnaby, A.; Jommi, C. | |
| Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study | 1-gen-2018 | Cozzolino, M.; Bolasco, P.; Ronco, C.; Conte, G.; Mene, P.; Mereu, M. C.; Di Luca, M.; Roccatello, D.; Rosati, A.; Jommi, C.; Costanzo, A. M.; Gualberti, G.; Di Luzio Paparatti, U.; Remuzzi, G. | |
| Unmet clinical need and new therapeutic options | 1-gen-2022 | Caprari, F.; Alfano, A.; Buzzetti, G.; Consoli, A.; De Braud, F.; Patarnello, F.; Pitrelli, A.; Riccaboni, M.; Rossi, G.; Samele, R.; Scaduto, D.; Viale, P.; Jommi, C.; Popoli, P. | |
| CAR T-Cell Therapies in Italy: Patient Access Barriers and Recommendations for Health System Solutions | 1-gen-2022 | Jommi, C.; Bramanti, S.; Pani, M.; Ghirardini, A.; Santoro, A. | |
| Costs and outcome of care in subjects with a severe mental disorder | 1-gen-2003 | Percudani, M.; Gerzeli, S.; Massagrandi, R.; Jommi, C.; Fattore, G.; Cerati, G.; Contini, A. | |
| The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study | 1-gen-2018 | Jommi, C.; Armeni, P.; Battista, M.; di Procolo, P.; Conte, G.; Ronco, C.; Cozzolino, M.; Costanzo, A. M.; di Luzio Paparatti, U.; Concas, G.; Remuzzi, G. | |
| Towards a more competitive Italy in clinical research: The survey of attitudes towards trial sites in Europe (the SAT-EU study™) | 1-gen-2015 | Gehring, M.; Jommi, C.; Tarricone, R.; Cirenei, M.; Ambrosio, G. | |
| Key drivers of innovativeness appraisal for medicines: The Italian experience after the adoption of the new ranking system | 1-gen-2021 | Galeone, C.; Bruzzi, P.; Jommi, C. | |
| Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations? | 1-gen-2021 | Ronco, V.; Dilecce, M.; Lanati, E.; Canonico, P. L.; Jommi, C. | |
| Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non–small Cell Lung Cancer in the Italian National Health Service | 1-gen-2020 | Armeni, P.; Borsoi, L.; Fornaro, G.; Jommi, C.; Grossi, F.; Costa, F. | |
| How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? | 1-gen-2023 | Drummond, Michael; Ciani, Oriana; Fornaro, Giulia; Jommi, Claudio; Dietrich, Eva Susanne; Espin, Jaime; Mossman, Jean; de Pouvourville, Gerard | |
| Operational strategies to deal with the COVID-19 emergency: recommendations from the Italian national society SIAGASCOT following the introduction of vaccines against the SARS-CoV-2 infection | 1-gen-2023 | Compagnoni, Riccardo; Cucchi, Davide; Klumpp, Raymond; Ronga, Mario; Berruto, Massimo; Di Giacomo, Giovanni; Randelli, Pietro S | |
| Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise - a review | 1-gen-2023 | Lubrano, Ennio; Scriffignano, Silvia; de Vlam, Kurt; Ronga, Mario; Perrotta, Fabio Massimo; Lories, Rik | |
| Real-world use of Safinamide in motor fluctuating Parkinson's disease patients in Italy | 1-gen-2023 | Bovenzi, Roberta; Liguori, Claudio; Canesi, Margherita; D'Amelio, Marco; De Pandis, Maria Francesca; Marini, Carmine; Monge, Alessandra; Padovani, Alessandro; Tessitore, Alessandro; Stefani, Alessandro; Zappia, Mario; SYNAPSES Study, Investigators Italian Group including; Comi, Cristoforo | |
| Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy | 1-gen-2023 | Cavaletti, Guido; Pizzamiglio, Chiara; Man, Albert; Engber, Thomas M; Comi, Cristoforo; Wilbraham, Darren |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista36149
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa64
- 2020 - 20269888
- 2010 - 201913041
- 2000 - 20097282
- 1990 - 19994152
- 1980 - 19891467
- 1970 - 1979232
- 1962 - 196924
Rivista
- PHYSICS LETTERS. SECTION B771
- JOURNAL OF HIGH ENERGY PHYSICS498
- PHYSICAL REVIEW LETTERS295
- THE EUROPEAN PHYSICAL JOURNAL. C,...284
- PHYSICAL REVIEW D234
- JOURNAL OF HIGH ENERGY PHYSICS183
- PLOS ONE181
- BLOOD169
- INTERNATIONAL JOURNAL OF MOLECULA...164
- NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
- Humans1437
- Female757
- Male607
- Middle Aged459
- Adult415
- Aged406
- COVID-19344
- Italy298
- Animals217
- Treatment Outcome196
Lingua
- eng24750
- ita5290
- fre259
- spa169
- ger58
- rus29
- und26
- por17
- lat15
- grc6
Accesso al fulltext
- no fulltext21426
- reserved7315
- open4967
- restricted2326
- partially open90
- embargoed17
- mixed9